Japan OKs World’s 1st iPS Cell-Based Products
Tokyo, March 6 (Jiji Press)–Japan’s health ministry said Friday it has conditionally approved the production and sales of two regenerative medical products using induced pluripotent stem cells. The approval was given to Tokyo-based startup Cuorips Inc.’s cardiac muscle cell sheet called “ReHeart”